A study of 11 million people found those who used CPAP machines to treat the disorder were less likely to develop the incurable neurological disease.

Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease ...

Untreated sleep apnea may play a role in Parkinson's disease development, a new study suggests, but early CPAP therapy shows ...

Fisher & Paykel Healthcare reported total operating revenue of $1.09 billion for the first half of the 2026 financial year, a ...

U.S. veterans with obstructive sleep apnea (OSA) had a significantly higher risk of developing Parkinson’s Disease, but this risk was reduced with early CPAP intervention, according to a ...

Obstructive sleep apnea (OSA) seems to be an independent risk factor for development of Parkinson disease, and early use of ...

Nyxoah today announced a significant reimbursement win through the U.S. Centers for Medicare & Medicaid Services (CMS).

The global Continuous Positive Airway Pressure (CPAP) market is positioned for notable growth over the forecast period from ...

Early treatment of obstructive sleep apnea may decrease the risk of Parkinson's disease, a new study published Monday finds.

Molecular profiles of oligodendrocytes and microglia in rhesus monkeys that followed a lifelong 30% calorie restriction diet ...

Participants with untreated sleep disorder were nearly twice as likely to develop the neurodegenerative condition, according ...